Improved Injection Precision of USP Methods with an Arc HPLC System

Importance of Topic

Accurate and reproducible sample injection is fundamental for quantitative high performance liquid chromatography in regulated environments. Stringent system suitability requirements defined by pharmacopeial monographs ensure measurement reliability and compliance. Factors such as highly organic diluents, large injection volumes and low analyte concentrations can challenge injection precision, potentially leading to failed assays and data variability.

Objectives and Study Overview

This work evaluates the injection precision of a novel Arc HPLC System under conditions defined by United States Pharmacopeia monographs for Azithromycin organic impurities, Quetiapine and Losartan potassium. Key aims include assessing precision for 100% organic diluents, strict precision criteria (relative standard deviation RSD ≤ 0.5%) and the impact of high injection volumes with low analyte concentrations. Comparative studies against other commercial HPLC systems demonstrate the Arc system’s performance advantages.

Methodology and Instrumentation

The Arc HPLC System autosampler employs a syringe combined with a degassed purge line to aspirate samples, supporting precise volumes up to 60 microliters with a 100 microliter syringe and extension loop. Standard conditions included a 10 degree sample cooler, independent needle and seal washes, and use of Empower 3 chromatography software for data management.

Each USP monograph was executed following specified mobile phases, column types and temperatures. Azithromycin analyses used a 4.6 by 250 mm C18 phase at 60 degrees, Quetiapine used a C8 column at 25 degrees and Losartan employed an HSS T3 phase at 35 degrees. Injection volumes ranged from 13.2 to 50 microliters, with flow rates between 1.0 and 1.32 milliliters per minute.

Main Results and Discussion

Single-day precision studies (n=5) yielded RSD values well below pharmacopeial limits. The Azithromycin method achieved 0.6% RSD for organic impurity analysis without specified injection precision criteria. Quetiapine and Losartan assays met the stringent RSD requirement of not more than 0.5%.

Inter-day studies of the Losartan monograph over three days confirmed consistently low RSD for peak area, stable retention times, acceptable tailing and column efficiency, all within USP system suitability specifications. Comparative trials against four other HPLC systems demonstrated the superior reproducibility of the Arc platform, with only one competitor matching suitability criteria and all Arc trials exhibiting the lowest RSD values.

Benefits and Practical Applications

• Reliable compliance with strict pharmacopeial injection precision requirements.
• Enhanced reproducibility for methods using highly volatile organic diluents and large injection volumes.
• Consistent performance across multiple days and assays, reducing method development time and failure rates.

Future Trends and Opportunities

Advancements in autosampler design may further reduce dead volumes and carryover, supporting even lower concentration assays. Integration of real time diagnostic feedback and adaptive purge protocols could optimize precision under varying sample matrices. Broader adoption of degassed purge systems and syringe based aspiration in routine workflows promises to improve method robustness across pharmaceutical, environmental and food safety laboratories.

Conclusion

The Arc HPLC System demonstrates exceptional injection precision under challenging United States Pharmacopeia method conditions. Its syringe plus independent degassed purge architecture ensures reproducible volumes even with organic solvents and high injection volumes, outperforming several comparable systems. This reliability supports routine compliance with strict system suitability criteria and enhances confidence in quantitative HPLC results.

Used Instrumentation

• Arc HPLC System with 30 microliter CHC
• 2998 Photodiode Array detector or 2489 Tunable UV detector
• Empower 3 version FR3 chromatography software
• C18, C8 and HSS T3 reversed phase columns (4.6 × 250 mm)

References

1. United States Pharmacopeia Azithromycin Organic Impurities Monograph, USP NF 43. 2020.
2. United States Pharmacopeia Quetiapine Fumarate Monograph, USP NF 43. 2020.
3. United States Pharmacopeia Losartan Potassium Monograph, USP NF 43. 2020.
4. United States Pharmacopeia General Chapter 621 Chromatography, USP NF 43. 2020.